			Home About us Contact

Sexual Intimacy (sexual + intimacy)

Distribution by Scientific Domains

Medical Sciences	50%
Humanities and Social Sciences	50%

Selected Abstracts

Homosexuality and the Church's Witness in the ELCA's Current Struggle

DIALOG, Issue 2 2005
By Marc Kolden
Abstract:, The basis for holding the traditional Christian position against same-sex sexual intimacy is sufficiently well-supported by arguments from scripture and Christian traditions of moral reasoning to vote to continue the present ELCA policies and practices regarding sexual conduct. Also, arguments for revising the traditional view are flawed morally and theologically. Despite the momentum of secular culture in North America and Europe, the ELCA should resist any changes in its policies and any relaxation in its disciplining of those who disregard its present practices. This will be difficult, because many proponents for change have raised their position to the level of a de facto article of faith, that is, something that they consider to be necessary (particularly as it concerns ordination), and thus they will do everything possible to secure acceptance of their position. [source]

Save the Young,the Elderly Have Lived Their Lives: Ageism in Marriage and Family Therapy,

FAMILY PROCESS, Issue 2 2000
David C. Ivey Ph.D.
The paucity of literature addressing mental health issues concerning geriatric populations represents the perpetuation of ageist practices and beliefs in the field of marriage and family therapy. The purpose of this study was to assess whether client age and clinical training relate to the evaluation of couples who present for conjoint therapy. Written vignettes describing two couples, one older and one younger, who report issues involving the absence of sexual intimacy, increased frequency of arguments, and increased use of alcohol were evaluated by practicing marriage and family therapists, therapists-in-training, and individuals with no clinical background. It was hypothesized that respondents' views would vary in connection with the age of the couple and with the three levels of participant training. Results indicate that client age and participant training are associated with perceptions of individual and couple functioning. Our findings suggest that the relational and mental health concerns experienced by elder couples are not perceived as seriously as are identical concerns experienced by younger couples. Contrary to our expectations the observed differences between views of the two age conditions did not significantly differ between levels of participant training. Training and experience in marriage and family therapy may not significantly mitigate vulnerability to age-discrepant views. [source]

The influence of caregiver burden on sexual intimacy and marital satisfaction in couples with an Alzheimer spouse

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, Issue 1 2008
C. Simonelli
Summary Objective:, This study investigates affective and sexual dimensions in partners involved as caregivers of Alzheimer dementia (AD) subjects. A negative correlation between burden of the caregiver and sexual-affective quality of life was assumed. Design and methods:, Hundred participants with AD partner (33 male, 67 female), aged between 55 and 85 years were recruited and data were collected from the Caregiver Burden Inventory scale and a semi-structured interview that included demographic information, medical history, relationship and sexual satisfaction, and current sexual function. AD group was compared with a control group (CG) (N = 100) matched for age, sex, education and marital status on measures of the semi-structured interview. Data were analysed using frequency count, univariate analysis (chi-squared and ANOVA) and bivariate correlation. Results:, The findings revealed that mean burden level was 31.59 (SD 19.51). A difference between experimental and CGs was found for sexual and affective marital satisfaction (p < 0.05). The same variables showed a rather negative correlation with total burden levels (r = ,0.374, p < 0.001; r = ,0.448, p < 0.001). [source]

Safety, Efficacy, and Pharmacokinetic Overview of Low-Dose Daily Administration of Tadalafil

THE JOURNAL OF SEXUAL MEDICINE, Issue 7 2009
Rebecca Wrishko PhD
ABSTRACT Introduction., Several phosphodiesterase type 5 (PDE5) inhibitors are commercially available for the treatment of erectile dysfunction (ED). Development of the first once-daily alternative dosing regimen with a PDE5 inhibitor was motivated by the behavioral complexities associated with sexual intimacy. Aim., To provide an alternative dosing option for certain men who may benefit from the removal of the temporal linkage between administration of an ED therapy and sexual intimacy or for men and their partners who anticipate at least twice-weekly sexual activity. Methods., Pharmacokinetic predictions of tadalafil plasma concentrations were generated based upon empirical data following 20-mg, single-dose administration coupled with tadalafil usage patterns from as-needed clinical trials. To support the pharmacokinetic simulations and pharmacodynamic assumptions, clinical trials were conducted to demonstrate the efficacy and safety of once-daily, low-dose tadalafil 2.5 and 5 mg. Main Outcome Measures., Simulated tadalafil plasma concentrations and comparison with safety and efficacy measures from clinical trials. Results., Based upon pharmacodynamic and pharmacokinetic data, once-daily doses of tadalafil 5 mg were predicted to provide therapeutic concentrations that would be maintained throughout the 24-hour dosing interval. Additionally, for a subgroup of men who anticipate at least twice-weekly sexual activity and are currently taking tadalafil 20 mg, a reduction in daily tadalafil exposure was predicted. To support the hypothesis that low-dose, once-daily tadalafil may be a safe and effective treatment alternative, clinical trials were conducted to demonstrate the safety and efficacy of once-daily tadalafil 2.5 and 5 mg. These results were similar to those of historical as-needed studies evaluating tadalafil 10 and 20 mg. Conclusions., Consistent with pharmacokinetic predictions, data from clinical trials indicate that once-daily use of low-dose tadalafil is a safe and effective treatment for men with ED. Wrishko R, Sorsaburu S, Wong D, Strawbridge A, and McGill J. Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. J Sex Med 2009;6:2039,2048. [source]